002349 Share Price Performance
CN¥7.15
-1.25 (-14.88%)
Price CN¥7.15
Share PriceCN¥7.15
There's No Escaping Jinghua Pharmaceutical Group Co., Ltd.'s (SZSE:002349) Muted Earnings
Jan 14
Jinghua Pharmaceutical Group Co., Ltd. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
002349 Community Narratives
There are no narratives available yet.
Recent 002349 News & Updates
Jinghua Pharmaceutical Group Co., Ltd. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
Oct 30, 2025
- Earnings per share (EPS)
- 0.25
- Gross Margin
- 49.91%
- Net Profit Margin
- 14.71%
- Debt/Equity Ratio
- 0.0003%
Jinghua Pharmaceutical Group Co., Ltd. Competitors
Snowflake Analysis
About 002349
- Founded
- 1957
- Employees
- 1490
- CEO
- WebsiteView website
Jinghua Pharmaceutical Group Co., Ltd. engages in the research and development, manufacture, and sale of APIs and pharmaceutical intermediates in China. Its primary products include Phenylbutazone, Primidone, Phenobarbital, Fluorouracil, Propylthiouracil, Piroxicam, and Flucytosine APIs. The company was formerly known as Nantong Jinghua Pharmaceutical Co., Ltd. The company was founded in 1957 and is based in Nantong, China.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Chinese Market Performance
- 7 Days: 1.8%
- 3 Months: 18.4%
- 1 Year: 24.1%
- Year to Date: 26.2%
In the last week, the market is up 1.8% led by Industrials sector. In the last year, the market has climbed 24%. As for the next few years, earnings are expected to grow by 27% per annum. Market details ›